Christopher Stewart
2020
In 2020, Christopher Stewart earned a total compensation of $252.4K as Chief Financial Officer at Bionano Genomics.
Compensation breakdown
| Non-Equity Incentive Plan | $23,400 |
|---|---|
| Option Awards | $210,500 |
| Salary | $18,027 |
| Other | $451 |
| Total | $252,378 |
Stewart received $210.5K in option awards, accounting for 83% of the total pay in 2020.
Stewart also received $23.4K in non-equity incentive plan, $18K in salary and $451 in other compensation.
Rankings
In 2020, Christopher Stewart's compensation ranked 12,349th out of 13,090 executives tracked by ExecPay. In other words, Stewart earned more than 5.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,349 out of 13,090 | 6th |
Division Manufacturing | 5,294 out of 5,624 | 6th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 742 out of 799 | 7th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 215 out of 227 | 5th |
Industry Laboratory Analytical Instruments | 76 out of 82 | 7th |
Source: SEC filing on April 27, 2021.
Stewart's colleagues
We found two more compensation records of executives who worked with Christopher Stewart at Bionano Genomics in 2020.